IP Library Granted Patent US 11,279,866
Granted Patent B2
US 11,279,866 · App. 16/909,505 · Granted Mar 22, 2022

Boosters for breakers containing iron compounds

Inventors: Jiang Li (Johns Creek, GA); Roopa Tellakula (Suwanee, GA)
Assignee: KEMIRA OYJ
C09K8/68C09K8/665C09K8/725C09K8/80C09K8/86C09K8/882E21B43/26E21B43/267
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,279,866
App. No.
16/909,505
Granted
Mar 22, 2022
Kind
B2
Abstract

Methods for fracturing a subterranean formation penetrated by a well bore are provided, the method comprising the step of injecting a well treatment fluid into the well bore at a pressure and flow rate sufficient to fracture the subterranean formation, wherein the well treatment fluid comprises one or more iron-containing compounds and one or more booster compounds. The methods can be used to reduce viscosity and to facilitate the decomposition of acrylamide-containing polymers.

Claims (22)

1. A well treatment fluid comprising water, one or more iron-containing compounds and one or more booster compounds, and at least one acrylamide-containing polymer,

wherein the one or more iron-containing compounds are selected from the group consisting of ferrous compounds, ferrous salts, ferric compounds, ferric salts, and mixtures thereof,

wherein the one or more booster compounds are selected from the group consisting of urea; ethylenediaminetetraacetic acid (EDTA); salts of EDTA, citric acid, aminotricarboxylic acid and its salt; polyphosphonated and poly phosphate compounds; boric acid and its salts; alkali metal salts of carbonates; diethylenetriaminepentaacetic acid (DTPA); humic acid; and lignosulfates,

wherein the combination of the one or more iron-containing compounds and the one or more booster compounds constitute a breaker composition sufficient to facilitate the breakdown of the at least one acrylamide-containing polymer in the absence of an oxidizer-based breaker.

2. The well treatment fluid of claim 1 , wherein the at least one acrylamide-containing polymer is in an amount of about 0.001% to about 5% of the well treatment fluid volume.

3. The well treatment fluid of claim 1 , wherein the one or more iron-containing compounds is in an amount of about 0.001% to about 0.2% of the well treatment fluid volume.

4. The well treatment fluid of claim 1 , wherein the one or more booster compounds are in an amount of about 0.001% to about 0.2% of the well treatment fluid volume.

5. The well treatment fluid of claim 1 , further comprising a proppant.

6. The well treatment fluid of claim 5 , wherein the proppant comprises sand.

7. The well treatment fluid of claim 1 , further comprising a crosslinking agent selected from the group consisting of borate, aluminum, antimony, zirconium, and titanium, and combinations thereof.

8. The well treatment fluid of claim 1 , wherein the one or more iron-containing compounds comprise a ferrous salt.

9. The well treatment fluid of claim 8 , wherein the ferrous salt is selected from the group consisting of ferrous chloride, ferrous bromide, ferrous fluoride, ferrous sulfate, ammonium iron sulfate, and combinations thereof.

10. The well treatment fluid of claim 1 , wherein the one or more iron-containing compounds comprise a ferric salt.

11. The well treatment fluid of claim 10 , wherein the ferric salt is selected from the group consisting of ferric citrate, ferric chloride, ferric bromide, ferric fluoride, ferric sulfate, and combinations thereof.

12. The well treatment fluid of claim 1 , wherein the at least one acrylamine-containing polymer is selected from the group consisting of: acrylamide homopolymers, copolymers, and terpolymers; polyacrylamide; polyacrylamide derivatives; methacrylamide homopolymers, copolymers, and terpolymers; diacetone acrylamide polymers; N-methylolacrylamide polymers; and combinations thereof.

13. The well treatment fluid of claim 1 , further comprising one or more additives selected from the group consisting of hydrochloric acid, acetic acid, sodium chloride, ethylene glycol, scale reducers, sodium carbonate, potassium carbonate, biocides, crosslinking agents, corrosion inhibitors, citric acid, non-emulsifiers, emulsifiers, iron control agents, delay additives, silt suspenders, flowback additives, isopropanol, methanol, and combinations thereof.

14. A well treatment fluid comprising water, a ferrous salt and one or more booster compounds, and at least one acrylamide-containing polymer;

wherein the at least one acrylamide-containing polymer is in an amount of about 0.001% to about 5% of the well treatment fluid volume;

wherein the ferrous salt is in an amount of about 0.001% to about 0.05% of the well treatment fluid volume;

wherein the one or more booster compounds are in an amount of about 0.001% to about 0.05% of the well treatment fluid volume;

wherein the one or more booster compounds are selected from the group consisting of urea; ethylenediaminetetraacetic acid (EDTA); salts of EDTA; citric acid; aminotricarboxylic acid and its salts; polyphosphonated and poly phosphate compounds; boric acid and its salts; alkali metal salts of carbonates; diethylenetriaminepentaacetic acid (DTPA); humic acids; and lignosulfates; and

wherein the combination of the ferrous salt and the one or more booster compounds constitute a breaker composition sufficient to facilitate the breakdown of the at least one acrylamide-containing polymer in the absence of an oxidizer-based breaker.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2024
From: KEMIRA OYJ
To: STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED
Reel/Frame 066699/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2020
From: LI, JIANG; TELLAKULA, ROOPA
To: KEMIRA OYJ
Reel/Frame 053022/0947 →
Continuity (3)
Division 15102629
Provisional Application 61922507 · Dec 31, 2013
Related Publication 20200397093A1 · Dec 24, 2020